Harte Hanks Valuation
Is HHS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Analyst Forecast
Key Valuation Metric
Which metric is best to use when looking at relative valuation for HHS?
Other financial metrics that can be useful for relative valuation.
| What is HHS's n/a Ratio? | |
|---|---|
| n/a Ratio | 0x |
| n/a | n/a |
| Market Cap | US$90.01m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.6x |
| Enterprise Value/EBITDA | 6.6x |
| PEG Ratio | -26x |
Price to Earnings Ratio vs Peers
How does HHS's PE Ratio compare to its peers?
| Company | PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 18.6x | ||
STBX Starbox Group Holdings | 45.1x | n/a | US$162.6m |
ADTH AdTheorent Holding Company | 3.7x | -19.5% | US$151.2m |
EEX Emerald Holding | 24.1x | n/a | US$269.9m |
ISIG Insignia Systems | 1.6x | n/a | US$16.0m |
HHS Harte Hanks | 6.3x | -0.2% | US$90.0m |
Price-To-Earnings vs Peers: HHS is good value based on its Price-To-Earnings Ratio (6.3x) compared to the peer average (18.6x).
Price to Earnings Ratio vs Industry
How does HHS's PE Ratio compare vs other companies in the US Media Industry?
Price to Earnings Ratio vs Fair Ratio
What is HHS's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 6.3x |
| Fair PE Ratio | 9.2x |
Price-To-Earnings vs Fair Ratio: HHS is good value based on its Price-To-Earnings Ratio (6.3x) compared to the estimated Fair Price-To-Earnings Ratio (9.2x).
Share Price vs Fair Value
What is the Fair Price of HHS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: HHS ($12.47) is trading below our estimate of fair value ($22.53)
Significantly Below Fair Value: HHS is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.